Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2026-06-12 16:28:12 ET · period of report 2026-06-11 · accession 0001836662-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Tang Carolyn C. | GC | M - OptEx | $2.57 | +34.1K | 184.6K | +23% | +$87.7K |
| D | 2026-06-12 16:28 | 2026-06-11 | RCUS | Tang Carolyn C. | GC | M - OptEx | $2.57 | -34.1K | 0 | -100% | -$87.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | M | A | 34,090 | $2.57 | 184,607 | D | — | — | (F1) Includes 1,783 shares purchased on May 31, 2026 through the Company's Employee Stock Purchase Plan. (F2) Includes the unvested portion of the Reporting Person's RSU grants. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-11 | M | D | 34,090 | $2.57 | 0 | D | $2.57 · — to 2027-08-30 | 34,090 Common Stock | (F3) The option is fully vested and has been completely exercised. |